» Authors » Sudesh Prabhakar

Sudesh Prabhakar

Explore the profile of Sudesh Prabhakar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 111
Citations 2102
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiels W, Oomens J, Engelborghs S, Baeken C, von Arnim C, Boada M, et al.
JAMA Psychiatry . 2025 Jan; 82(3):296-310. PMID: 39841452
Importance: Depressive symptoms are associated with cognitive decline in older individuals. Uncertainty about underlying mechanisms hampers diagnostic and therapeutic efforts. This large-scale study aimed to elucidate the association between depressive...
2.
Kaur S, Singh A, Prabhakar S, Singhvi J, Mann H, Kaul A
J Mov Disord . 2023 Jul; 16(3):336-338. PMID: 37424073
No abstract available.
3.
Rishi V, Singh R, Goyal M, Modi M, Garg V, Thakur J, et al.
Neurol India . 2022 Dec; 70(6):2383-2387. PMID: 36537420
Purpose: The association between exposure to Toxocara canis and epilepsy is at the best contentious. Most of previous studies were retrospective, community-based, and contradictory to one another. As the impact...
4.
Khurana D, Petluri G, Kumar M, Bahl A, Kumar A, Gairolla J, et al.
Neurol India . 2022 Jul; 70(3):1077-1082. PMID: 35864642
Background: : Strokes of the undetermined cause or cryptogenic strokes (CS) account for 30-40% of ischemic strokes. Paradoxical embolism secondary to patent foramen ovale (PFO) may be associated with CS....
5.
Jansen W, Janssen O, Tijms B, Vos S, Ossenkoppele R, Visser P, et al.
JAMA Neurol . 2022 Jan; 79(3):228-243. PMID: 35099509
Importance: One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and on positron emission tomography (PET) scans....
6.
Prabhakar S, Vishnu V, Modi M, Mohanty M, Sharma A, Medhi B, et al.
Ann Indian Acad Neurol . 2021 Mar; 23(6):767-773. PMID: 33688125
Objectives: Alzheimer's disease (AD) is the most common cause of dementia worldwide in the older population. There is no disease-modifying therapy available for AD. The current standard of care drug...
7.
Garg V, Goyal M, Khullar M, Saikia B, Medhi B, Prakash A, et al.
Indian J Pharmacol . 2020 Dec; 52(5):378-382. PMID: 33283769
Objectives: The objectives of this study were to determine the relationship between genetic polymorphisms in gene encodings for CYP3A4 and carbamazepine (CBZ)-induced dose-related side effects in North Indian people with...
8.
Anand A, Prabhakar S, Thakur K, Tyagi R, Shastri V, Tripathi D, et al.
J Neurosci Rural Pract . 2020 May; 11(2):256-260. PMID: 32367980
 The past three decades have seen palmistry as an interface to human health. There have been no previously organized attempts in utilizing this knowledge to predict the state of disease.  ...
9.
Modi M, Singh R, Goyal M, Gairolla J, Singh G, Rishi V, et al.
Ann Indian Acad Neurol . 2018 Dec; 21(4):263-269. PMID: 30532354
Objectives: Many community-based and hospital-based studies across the world have yielded contradictory results regarding association of positive serology and epilepsy. The present study was planned to analyze disease burden of...
10.
Mattsson N, Groot C, Jansen W, Landau S, Villemagne V, Engelborghs S, et al.
Alzheimers Dement . 2018 Mar; 14(7):913-924. PMID: 29601787
Introduction: Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier studies did not require biomarker evidence of amyloid...